HomeNews & TopicsInfection ControlThe world’s first vaccine against Chlamydia

The world’s first vaccine against Chlamydia

Published on

By Sebastian Dobosz

Researchers at St. Joseph’s Healthcare Hamilton have taken the first steps towards a widely protective vaccine against chlamydia.

Chlamydia is one of the most common sexually transmitted infections and affects 113 million people around the world. The disease causes pelvic pain in women, leads to other infections, and can cause irreversible damage resulting in infertility. As many chlamydia infections are asymptomatic, they can go untreated and cause damage without the patient being aware of the infection.

While chlamydia is currently treated with antibiotics, a vaccine would prevent the infection from occurring in the first place. This could potentially protect millions of people from chlamydia.

The researchers successfully tested a new recombinant antigen called BD584 in animal models with a common strain of chlamydia. The vaccine was delivered into the nose and protected the mice from genital tract infection as well as its damaging symptoms.

“The BD584 vaccine candidate is a fusion protein consisting of three genetically engineered proteins fused together,” says Dr. James Mahony, virologist at St. Joseph’s Healthcare Hamilton and the study’s senior author. “The vaccine elicits the production of antibodies that can block an essential virulence factor of chlamydia required for infection of cells therefore rendering the bacteria incapable of infection.”

The study showed that BD584 reduces chlamydial replication and shedding in the lower genital tract by 95 per cent, which is what enables the bacteria to spread to the upper genital tract. The vaccine also decreased pathology of the fallopian tubes by 87.5%.  Dr. Mahony explained that chlamydial infection of the upper genital tract leads to fluid filled fallopian tubes that block fertilization of eggs.

“The advantage of our vaccine is that it provides protection against all strains of Chlamydia that infect the genital tract. It is the first vaccine to provide this wide scale coverage,” says Dr. Mahony. “It will also protect against those strains of Chlamydia trachomatis that cause conjunctivitis in the eye leading to scarring trachoma and blindness which affects between six to nine million people around the world.”

Dr. Mahony notes that future research on other animal models will need to be done before the vaccine is tested in human trials. Further research will also test the effectiveness of this vaccine against different strains of chlamydia.

Sebastian Dobosz is a Research Communications Officer at St. Joseph’s Healthcare Hamilton.

Latest articles

Easing the Transition to the Cloud. Modernizing made simple with integration support.

Across Canada, most hospitals and healthcare authorities recognize the need to modernize their systems....

Rovolutionizing geriatric care: Meet Canada’s leading Universal Health Hub (UHH)

Universal Health Hub (UHH) is the only Health Care Organization in Canada which is...

National efforts to guide safe, effective, and equitable use of opioids for quality pain management in children

No one should experience untreated pain. Yet, in Canada, two out of three children...

Wait times in healthcare often linked to diagnostic testing – adding more doctors and nurses alone won’t improve that bottleneck

There is an emerging consensus that Canada’s healthcare system is in crisis.  Stories appear in...

More like this

COVID-19 rapid tests: How good are they?

A new study indicates that COVID-19 self-tests effectively identify non-infected individuals as well people...

Pressure injury education – offering potentially life-saving approach to skin health

When Jay De Alwis was admitted to Toronto Rehab, Lyndhurst Centre following spinal hematoma...

An ER doctor’s experience with long COVID – “My symptoms seemed endless”

On April 2022, another COVID wave was sweeping Toronto. It was the sixth since...

Product Spotlight: Greening Health Care, Cleaning and Disinfecting

(Advertisement) PCS Four-Fold Wipes Hypochlorous Acid and Sodium Hypochlorite compatible can be dispensed from the...

Researching a new treatment for sepsis

For people who are in the intensive care unit (ICU) with a serious health...

Polycystic ovarian syndrome: new review to help diagnose and manage

A new review in CMAJ (Canadian Medical Association Journal) is aimed at helping clinicians...